Weight loss is a core recommendation and should be achieved through a combination of reduced calorie intake and increased physical activity. The BP-lowering effect of weight loss in patients with elevated BP is consistent with the corresponding effect in patients with established HTN, with an apparent dose–response relationship of about 1 mmHg per kg of weight loss. Achievement andmaintenance of weight loss through behavior change are challenging but feasible over prolonged periods of follow-up. For those who do not meet their weight loss goals with nonpharmacological interventions, pharmacotherapy (such as GLP-1s) or bariatric procedures can be considered.